Shantell M. Kirkendoll

PCSK9-inhibitors in new cholesterol medications can help previously intolerant patients lower cholesterol. Here's more information on this new cholesterol drug.

University of Michigan Study shows that Low FODMAP diets can improve symptoms in patients with irritable bowel syndrome. Read more about Low FODMAP and IBS.

Are colonoscopies better at colorectal cancer detection than stool-based tests? University of Michigan gastroenterologist weighs in on colon cancer tests.

Doctors of Tomorrow pairs first-year medical students with ninth-grade mentees to foster diversity in medical fields.

University of Michigan professor finds survival rate for patients with liver disease improved with specialty care. Learn more about this paper on liver disease.

New medication limits the need for antiplatelet therapy leading up to cardiac procedures. Here's what P2Y12 inhibitors are being used intra- or post-procedural.

A portable total artificial heart device grants patients freedom while they wait for a donor and heart transplant.

A University of Michigan physician testified before lawmakers on the pharmaceutical company Valeant’s practice of raising prices on specialized niche drugs.

University of Michigan researchers have developed a new model to study cancer-associated thrombosis and are getting preliminary data for future research.

University of Michigan cardiologist believes that despite new blood thinning drugs taken orally, anticoagulation clinics will continue serving patients.

TAVR changed the landscape for high-risk patients in need of new aortic heart valves. Now, new data supports the viability of TAVR out to three years.

Research from the University of Michigan Hepatology Program reminds physicians that drugs their patients commonly use may cause liver injury or failure.